Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesMethylphenidate Side Effects in Advanced Cancer: A Retrospective Analysis
American Journal of Hospice and Palliative Medicine, 09/11/09
Lasheen W et al. – Treatment with Methylphenidate (MP) (10–20 mg/d) in advanced cancer is well tolerated. S/E symptoms with MP appeared to improve spontaneously despite continued MP therapy. Depression and fatigue improved at doses lower than those recommended in other clinical conditions. MP improved depression and fatigue, and some secondary symptoms associated with them. Methylphenidate (MP) appears safe when used in the treatment of depression and fatigue in advanced cancer.
Related Articles
Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion
Current Medical Research and Opinion, 11/18/09
Relevance Score: 85%
Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials
Clinical Therapeutics, 10/13/09
Relevance Score: 85%
Adolescent Girls With Attention-Deficit/Hyperactivity and Borderline Personality Disorders
Clinical Neuropharmacology, 10/12/09
Relevance Score: 83%
Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October
Shire, 10/30/09
Relevance Score: 80%
A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder
Journal of the American Academy of Child and Adolescent Psychiatry, 10/29/09
Relevance Score: 80%
Today in Pain Management/Palliative Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Provision of Spiritual Care to Patients With Advanced Cancer: Associations With Medical Care and Quality of Life Near Death
Journal of Clinical Oncology, 12/18/09
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor